Showing results (241-250 of 679) with videos related to

Sort By:
Pageof 68
Human Immunology|August 12, 2009
In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypesErick C Castelli, Philippe Moreau, Alynne Oya e Chiromatzo, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
How to manage neutropenia in multiple myelomaAntonio Palumbo, Jon Bladé, Mario Boccadoro, et al.
Leukemia|April 4, 2019
CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophagesAntonin Papin, Benoit Tessoulin, Céline Bellanger, et al.
Ejhaem|July 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matchingPhilippe Moreau, Cyrille Hulin, Sonja Zweegman, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 19, 2013
Association of HLA-G 3'UTR polymorphisms with response to malaria infection: a first insightAndré Garcia, Jacqueline Milet, David Courtin, et al.
Leukemia Research|July 26, 2005
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemiaPatrice Chevallier, Virginie Roland, Béatrice Mahé, et al.
Haematologica|August 16, 2023
Isatuximab plus carfilzomib and dexamethasone in patients with early versus late relapsed multiple myeloma: IKEMA subgroup analysisThierry Facon, Philippe Moreau, Ross Baker, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting TherapyTitouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.
Leukemia Research|September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMAMeral Beksac, Ivan Spicka, Roman Hajek, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES StudyPierre Peterlin, Cécile Chauvin, Steven Le Gouill, et al.
Pageof 68